文献速递心血管胸部CT

冠状动脉周围脂肪衰减指数对合并糖尿病的冠状动脉疾病患者的增量预后价值

Incremental Prognostic Value of Perivascular Fat Attenuation Index in Patients with Diabetes with Coronary Artery Disease.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

前瞻性纳入2015年1月至2017年12月因疑似冠心病行冠状动脉CT血管成像的连续2型糖尿病患者1029例,中位随访56.5个月,152例(14.8%)发生主要不良心脑血管事件;冠状动脉周围脂肪衰减独立预测事件(HR 1.86,95%CI 1.24–2.80,P=.003),含该指标的模型AUC 0.75 vs 0.73(P=.009),显示增量预后价值。

要点

  • 冠状动脉周围脂肪衰减指数可独立预测糖尿病患者主要不良心脑血管事件(HR 1.86)。
  • 在临床特征及常规与进阶CCTA参数基础上,加入脂肪衰减指数使AUC由0.73升至0.75(P=.009)。
  • 中位随访56.5个月期间,1029例中152例(14.8%)发生主要不良心脑血管事件。

核心结论

  • 在糖尿病患者中,冠状动脉周围脂肪衰减指数在临床特征及其他CCTA表现之外,对主要不良心脑血管事件的预测具有增量预后价值。

研究设计与样本

  • 前瞻性研究,连续纳入2015年1月至2017年12月因疑似冠状动脉疾病行CCTA的2型糖尿病患者1029例(平均年龄60.2岁±9.9[标准差],男性539例),测量并评估三支冠状动脉的冠状动脉周围脂肪衰减指数。

诊断标准与关键数值

  • 冠状动脉周围脂肪衰减指数独立预测主要不良心脑血管事件:风险比1.86(95%CI 1.24,2.80;P=.003)。

临床应用与阅片要点

  • 模型4(模型3+冠状动脉周围脂肪衰减指数)预测主要不良心脑血管事件的AUC为0.75(95%CI 0.71,0.79),优于模型3(临床特征+常规CCTA表现+进阶CCTA表现)的AUC 0.73(95%CI 0.68,0.77),差异P=.009。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate whether pericoronary adipose tissue attenuation (PCATa) provides incremental prognostic value over commonly used coronary CT angiography (CCTA) parameters for predicting major adverse cardiovascular and cerebrovascular events (MACCE) in individuals with diabetes mellitus (DM). Materials and Methods This prospective study included consecutive patients with type 2 DM who underwent CCTA due to suspected coronary artery disease between January 2015 and December 2017. PCATa of three coronary arteries was measured and evaluated. Cox proportional hazards regression was performed to investigate the prognostic value of PCATa for predicting MACCE. The incremental prognostic value of PCATa for MACCE was evaluated by comparing area under the receiver operating characteristic curve (AUC) values of four models (model 1: clinical characteristics, model 2: model 1 + conventional CCTA findings [coronary artery calcium score, Leiden score], model 3: model 2 + advanced CCTA findings [high-risk plaque, CT fractional flow reserve], model 4: model 3 + PCATa). Results Of the 1029 participants (mean age, 60.2 years ± 9.9 [SD]; 539 male) included in the study, 152 (14.8%) experienced MACCE during a median follow-up of 56.5 months. PCATa independently predicted MACCE after adjustment for clinical characteristics and commonly used CCTA findings (hazard ratio, 1.86 [95% CI: 1.24, 2.80]; P = .003). The model incorporating PCATa improved predictive performance for MACCE compared with the model including clinical characteristics and conventional and advanced CCTA parameters (AUC, 0.75 [95% CI: 0.71, 0.79] vs 0.73 [95% CI: 0.68, 0.77]; P = .009). Conclusion PCATa provided incremental prognostic value beyond clinical characteristics and other CCTA findings for prediction of MACCE in individuals with DM. Keywords: CT Angiography, Cardiac, Coronary Arteries, Inflammation, Outcomes Analysis, Coronary Computed Tomography Angiography, Diabetes Mellitus, Coronary Inflammation, Pericoronary Adipose Tissue Attenuation Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Ding Y, Shan D, Han T, et al. Incremental Prognostic Value of Perivascular Fat Attenuation Index in Patients with Diabetes with Coronary Artery Disease. Radiol Cardiothorac Imaging. 2025. PMID: 40042997. doi:10.1148/ryct.240242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。